{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:31:40Z","timestamp":1762918300866,"version":"build-2065373602"},"reference-count":37,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives: Because few data are available, the aim of this study is to analyze the effects of antithrombotic agents (ATAs) on visual function and long-term risk of cardiovascular events and mortality in hypertensive patients with retinal vein occlusion (RVO). Materials and methods: Hypertensive patients with RVO were consecutively selected from 2008 to 2012 and followed for a median of 8.7 years. Ophthalmologists evaluated and treated RVO complications, and best-corrected visual acuity (BCVA) was checked at each visit during the first one year of follow-up. Survival analysis was conducted on the rate of the composite endpoint of all-cause deaths or non-fatal cardiovascular events. Results: Retrospectively, we collected data from 80 patients (age 68 \u00b1 12 years, 39 males). Central and branch RVO was present in 41 and 39 patients, respectively, and 56 patients started ATAs (50 antiplatelet drugs, 6 warfarin, and 2 low-molecular weight heparin). Average BCVA of the cohort did not change significantly during one-year of follow-up. The only predictor of BCVA was the baseline BCVA value. There was a reduction in proportion and severity of macular edema and an increase in the cumulative proportion of retinal vein patency reestablishment during the follow-up, independent of treatment. ATAs had no effects on one-year BCVA, intraocular complications, or the composite endpoint rate. Conclusions: In this exploratory study, ATAs had no effect on BCVA during the first one year of follow-up and on the composite endpoint during the long-term follow-up. Further prospective studies need to be conducted with an accurate standardization of the intraocular and antithrombotic treatment to define the positive or negative role of ATAs in hypertensive patients with RVO.<\/jats:p>","DOI":"10.3390\/medicina57101017","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T10:39:20Z","timestamp":1632739160000},"page":"1017","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of Antithrombotic Agents on Ophthalmological Outcomes, Cardiovascular Risk, and Mortality in Hypertensive Patients with Retinal Vein Occlusion: An Exploratory Retrospective Study"],"prefix":"10.3390","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9526-9472","authenticated-orcid":false,"given":"Federica","family":"Bertoli","sequence":"first","affiliation":[{"name":"Division of Ophthalmology, Monfalcone-Gorizia Hospital (ASUGI), 34074 Monfalcone, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Bais","sequence":"additional","affiliation":[{"name":"Thrombosis Prevention Unit, Division of Internal Medicine, Academic Hospital of Udine (ASUFC), 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"De Silvestri","sequence":"additional","affiliation":[{"name":"Thrombosis Prevention Unit, Division of Internal Medicine, Academic Hospital of Udine (ASUFC), 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Mariotti","sequence":"additional","affiliation":[{"name":"Thrombosis Prevention Unit, Division of Internal Medicine, Academic Hospital of Udine (ASUFC), 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Veritti","sequence":"additional","affiliation":[{"name":"Department of Medicine-Ophthalmology, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2726-5714","authenticated-orcid":false,"given":"Alessandro","family":"Cavarape","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Catena","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3746-141X","authenticated-orcid":false,"given":"Paolo","family":"Lanzetta","sequence":"additional","affiliation":[{"name":"Department of Medicine-Ophthalmology, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo Alberto","family":"Sechi","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1673-540X","authenticated-orcid":false,"given":"GianLuca","family":"Colussi","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Department of Medicine, University of Udine, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMcp1003934","article-title":"Retinal-Vein Occlusion","volume":"363","author":"Wong","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.atherosclerosis.2016.02.024","article-title":"Retinal vein occlusion and risk of cerebrovascular disease and myocardial infarction: A meta-analysis of cohort studies","volume":"247","author":"Zhong","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ophtha.2007.01.031","article-title":"Mortality in patients with branch retinal vein occlusion","volume":"114","author":"Christoffersen","year":"2007","journal-title":"Ophthalmology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ophtha.2013.07.025","article-title":"Mortality in patients with central retinal vein occlusion","volume":"121","author":"Bertelsen","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ophtha.2004.10.039","article-title":"Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: The Atherosclerosis Risk in Communities & Cardiovascular Health studies","volume":"112","author":"Wong","year":"2005","journal-title":"Ophthalmology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/archopht.126.5.692","article-title":"Retinal Vein Occlusion and Traditional Risk Factors for Atherosclerosis","volume":"126","author":"Wong","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/jth.12982","article-title":"Prevalence and risk factors of retinal vein occlusion: The Gutenberg Health Study","volume":"13","author":"Ponto","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_8","first-page":"e534","article-title":"Impact of cardiovascular risk factors on incidence and severity of Retinal Vein Occlusion","volume":"171","author":"Pacella","year":"2020","journal-title":"Clin. Ter."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e5185","DOI":"10.1097\/MD.0000000000005185","article-title":"Prevalence and associated factors of retinal vein occlusion in the Korean National Health and Nutritional Examination Survey, 2008\u20132012","volume":"95","author":"Shin","year":"2016","journal-title":"Medicine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.jhh.1001472","article-title":"Hypertension and the eye: Changing perspectives","volume":"16","author":"Chatterjee","year":"2002","journal-title":"J. Hum. Hypertens."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1160\/TH09-09-0626","article-title":"Antithrombotic and fibrinolytic drugs for retinal vein occlusion: A systematic review and a call for action","volume":"103","author":"Manfredi","year":"2010","journal-title":"Thromb. Haemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ophtha.2006.11.011","article-title":"Interventions for central retinal vein occlusion: An evidence-based systematic review","volume":"114","author":"Mohamed","year":"2007","journal-title":"Ophthalmology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/ajh\/hpt231","article-title":"Fish meal supplementation and ambulatory blood pressure in patients with hypertension: Relevance of baseline membrane fatty acid composition","volume":"27","author":"Colussi","year":"2014","journal-title":"Am. J. Hypertens."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/jop.2018.0153","article-title":"Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa","volume":"36","author":"Veritti","year":"2020","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1097\/IAE.0000000000002299","article-title":"Twelve-month outcomes of intravitreal aflibercept for neovascular age-related macular degeneration: Fixed versus as-needed dosing","volume":"39","author":"Veritti","year":"2019","journal-title":"Retina"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000484350","article-title":"A Pathogenetic Classification of Diabetic Macular Edema","volume":"60","author":"Battaglia","year":"2018","journal-title":"Ophthalmic. Res."},{"key":"ref_18","unstructured":"R Core Team (2020). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Available online: https:\/\/www.R-project.org\/."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0161-6420(90)32379-5","article-title":"The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion","volume":"97","author":"Elman","year":"1990","journal-title":"Ophthalmology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10384-019-00676-5","article-title":"Arteriovenous crossing associated with branch retinal vein occlusion","volume":"63","author":"Muraoka","year":"2019","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF01007831","article-title":"Thrombus and branch retinal vein occlusion","volume":"235","author":"Baglivo","year":"1997","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/01.HYP.36.6.978","article-title":"Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension","volume":"36","author":"Sechi","year":"2000","journal-title":"Hypertension"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcjo.2018.04.014","article-title":"Mean platelet volume and central retinal vein occlusion in hypertensive patients","volume":"54","author":"Bawankar","year":"2019","journal-title":"Can. J. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Browning, D.J. (2012). Pathophysiology of Retinal Vein Occlusions. Retin Vein Occlusions Evid-Based Manag, Springer.","DOI":"10.1007\/978-1-4614-3439-9"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000073587","article-title":"Retinal vein thrombosis: Risk factors, pathogenesis and therapeutic approach","volume":"32","author":"Prisco","year":"2002","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000502041","article-title":"Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA)","volume":"242","author":"Gerendas","year":"2019","journal-title":"Ophthalmologica"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.thromres.2009.05.007","article-title":"Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study","volume":"125","author":"Ageno","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_28","first-page":"418","article-title":"Dalteparin versus aspirin in recent-onset branch retinal vein occlusion: A randomized clinical trial","volume":"11","author":"Farahvash","year":"2008","journal-title":"Arch. Iran. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1538-7836.2010.03909.x","article-title":"Retinal vein thrombosis: Pathogenesis and management","volume":"8","author":"Rehak","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4816527","DOI":"10.1155\/2017\/4816527","article-title":"Mystery of Retinal Vein Occlusion: Vasoactivity of the Vein and Possible Involvement of Endothelin-1","volume":"2017","author":"Kida","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd724","article-title":"Novel drug development opportunities for heparin","volume":"1","author":"Lever","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.fjc.0000159878.66325.fc","article-title":"Comparison of the Vasodilatory Effect of Nadroparin, Enoxaparin, Dalteparin, and Unfractioned Heparin in Human Internal Mammary Artery","volume":"45","author":"Tasatargil","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ophtha.2011.04.036","article-title":"Central and hemicentral retinal vein occlusion: Role of anti-platelet aggregation agents and anticoagulants","volume":"118","author":"Hayreh","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3324\/haematol.2010.023614","article-title":"Low molecular weight heparin for the treatment of retinal vein occlusion: A systematic review and meta-analysis of randomized trials","volume":"95","author":"Hawel","year":"2010","journal-title":"Haematologica"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/IAE.0000000000002472","article-title":"Association of retinal vein occlusion with cardiovascular events and mortality: A systematic review and meta-analysis","volume":"39","author":"Wu","year":"2019","journal-title":"Retina"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijcard.2014.10.110","article-title":"Bidirectional association between the risk of comorbidities and the diagnosis of retinal vein occlusion in an elderly population: A nationwide population-based study","volume":"178","author":"Shih","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajo.2008.08.006","article-title":"Retinal Vein Occlusion and the Risk of Stroke Development: A Five-year Follow-up Study","volume":"147","author":"Ho","year":"2009","journal-title":"Am. J. Ophthalmol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/10\/1017\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:05:00Z","timestamp":1760166300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/10\/1017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,25]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["medicina57101017"],"URL":"https:\/\/doi.org\/10.3390\/medicina57101017","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2021,9,25]]}}}